An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
about
Antisense-mediated exon skipping: a versatile tool with therapeutic and research applicationsAsyn-anticonformational difference allows SRSF2 to recognize guanines and cytosines equally wellInterplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouseIdentification of small molecule and genetic modulators of AON-induced dystrophin exon skipping by high-throughput screeningIdentification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in developmentRNA and diseaseAntagonistic factors control the unproductive splicing of SC35 terminal intron.RNA splicing regulated by RBFOX1 is essential for cardiac function in zebrafish.Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues.Nonsense mutation-associated Becker muscular dystrophy: interplay between exon definition and splicing regulatory elements within the DMD gene.Personalized exon skipping strategies to address clustered non-deletion dystrophin mutations.Interplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes.Human Splicing Finder: an online bioinformatics tool to predict splicing signals.Chemical treatment enhances skipping of a mutated exon in the dystrophin gene.FUBP1: a new protagonist in splicing regulation of the DMD geneEarly-progressive dilated cardiomyopathy in a family with Becker muscular dystrophy related to a novel frameshift mutation in the dystrophin gene exon 27An intronic element contributes to splicing repression in spinal muscular atrophy.Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophyMutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.hnRNP H enhances skipping of a nonfunctional exon P3A in CHRNA1 and a mutation disrupting its binding causes congenital myasthenic syndromeDMD exon 1 truncating point mutations: amelioration of phenotype by alternative translation initiation in exon 6.RNA processing and mRNA surveillance in monogenic diabetes.The incredible complexity of RNA splicing.A classification model relative to splicing for variants of unknown clinical significance: application to the CFTR gene.hnRNP A1: the Swiss army knife of gene expression.Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms.Alternative splicing as a biomarker and potential target for drug discovery.RNA mis-splicing in disease.Binding of DAZAP1 and hnRNPA1/A2 to an exonic splicing silencer in a natural BRCA1 exon 18 mutant.Random Splicing of Several Exons Caused by a Single Base Change in the Target Exon of CRISPR/Cas9 Mediated Gene Knockout.Targeting Splicing in the Treatment of Human DiseaseFaulty RNA splicing: consequences and therapeutic opportunities in brain and muscle disorders.Normal and altered pre-mRNA processing in the DMD gene.Targeted RNA-Seq profiling of splicing pattern in the DMD gene: exons are mostly constitutively spliced in human skeletal muscleIdentification of Splicing Factors Involved in DMD Exon Skipping Events Using an In Vitro RNA Binding Assay.Clinical Utility Gene Card for: Becker muscular dystrophy.Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertension
P2860
Q24682555-BC207265-CBCF-49D2-94BA-705406E3E3D6Q27675089-3EEF2D12-807B-4F59-A254-98BBF6EE747CQ28469191-C8D06E8D-B9CD-4984-80EC-BD3C9AF90583Q28472268-E0E49C77-C214-468D-BA6E-FA038D943BFAQ28588811-7ACE0F16-E722-4A2A-A466-EEB070C9C989Q29615183-F9D6D7B2-E342-42FC-B2E8-48A6A72EB47CQ30493457-7B58B735-6C74-4A1D-BD67-DD8EE51E0E82Q30661669-1B78CF11-E317-4607-99FD-1C17DF71E5FEQ33390501-BBC47FBF-C2E3-4E1D-839D-9E7BCA89EFC9Q34221402-FA21F32E-2669-4B75-B71D-DC7D47E20ECEQ34349200-1542A8B1-7B59-4D9A-9B47-B682B35D0B55Q34639835-B636EE18-2435-43D1-AEA8-1269FB84A0EAQ34973311-BD4988D9-2A43-4409-AAFE-093B697910ABQ35039875-321BCD55-1233-40C6-9128-67B70872933EQ35131165-2EF5AE4B-2FF1-4BB3-9F46-329681BCE07EQ35220292-168811FC-5F87-4CF4-BFFF-42F3A4D167D9Q35652570-785F3CD9-0F89-4796-8E65-8D4D333622A6Q36109634-866114EA-7EDF-4F96-9E77-EF35A040652FQ36116293-CBD249C7-46F4-4C90-83CF-27C28FC426BBQ37089623-4AD54842-864D-4845-9E1A-B0B5C52400F4Q37144701-B97E63E6-94FE-446D-A948-8DF02CF58DD5Q37321839-CE13127A-50BB-465B-9704-9E8311B5B86DQ37547135-04055A09-D1AC-4151-85E1-6F526BB120A6Q38079179-72D79630-6055-46DA-BD79-EF11C61585E1Q38142712-244D9034-DFA8-4455-9A25-E35DC7E40B39Q38360555-90A0CDC0-F190-49E7-BC70-96595F12B142Q38527484-CFD6BD10-EA74-44B2-B67F-D85BFC85F4CCQ38642996-B3AE6438-4958-4ECB-8AF0-C6CFF555A123Q39026940-BBC5EB0F-4F12-470E-AA83-103F3D39A354Q39095073-50D5A652-CC51-4A5E-9A56-7C54D2D1C5FAQ39154733-91C61C82-B414-48EF-9CD0-3E3447329D41Q39256785-79225677-228E-4674-8A4F-F78FE17CCD6EQ39361232-A4F2C5BF-FC98-4B01-9397-0EDA0AA818B9Q40547402-66354BF8-AE8E-43F6-A021-903AF9D6646CQ47606978-D2DEB75B-9359-49B7-ABD6-AFBC7E4CCEB9Q54269189-CA48A271-F354-4066-AFA5-52CD62BDB2BEQ57148975-565738D2-531A-4E71-9F12-6947068231F1
P2860
An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
An exon skipping-associated no ...... ntagonistic splicing elements.
@en
An exon skipping-associated no ...... ntagonistic splicing elements.
@nl
type
label
An exon skipping-associated no ...... ntagonistic splicing elements.
@en
An exon skipping-associated no ...... ntagonistic splicing elements.
@nl
prefLabel
An exon skipping-associated no ...... ntagonistic splicing elements.
@en
An exon skipping-associated no ...... ntagonistic splicing elements.
@nl
P2093
P2860
P356
P1476
An exon skipping-associated no ...... ntagonistic splicing elements.
@en
P2093
J Stevenin
M Claustres
N Benmalek
P2860
P304
P356
10.1093/HMG/DDL015
P577
2006-02-06T00:00:00Z